OPTIBIOTIX HLTH PLC LS-02

OPTIBIOTIX HLTH PLC LS-02

Share · GB00BP0RTP38 · A118S6 (XLON)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of OPTIBIOTIX HLTH PLC LS-02
No Price
Closing Price XLON 29.04.2026: 4,70 GBX
29.04.2026 07:36
Current Prices from OPTIBIOTIX HLTH PLC LS-02
ExchangeTickerCurrencyLast TradePriceDaily Change
XLON: London
London
OPTI.L
GBX
29.04.2026 07:36
4,70 GBX
-0,15 GBX
-3,09 %
Share Float & Liquidity
Free Float 89,84 %
Shares Float 92,81 M
Shares Outstanding 103,3 M
Company Profile for OPTIBIOTIX HLTH PLC LS-02 Share
OptiBiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that is used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; WellBiome, a functional fibre and mineral blend that supports health & wellbeing by promoting the diversity of the gut microbiome; and Sweetbiotix, a sweetener for use in food and beverages. The company's products prevents and manages chronic lifestyle diseases, including obesity, hypercholesterolemia and lipid profiles, and diabetes. OptiBiotix Health Plc was founded in 2012 and is headquartered in York, the United Kingdom.

Company Data

Name OPTIBIOTIX HLTH PLC LS-02
Company OptiBiotix Health Plc
Website https://opmc.com.ph
Primary Exchange XLON London
WKN A118S6
ISIN GB00BP0RTP38
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Stephen Patrick O'Hara
Market Capitalization 11 Mio
Country United Kingdom
Currency GBP
Employees 0,0 T
Address Innovation Centre, YO10 5DG York
IPO Date 2011-09-09

Stock Splits

Date Split
05.08.2014 1:200
04.02.2014 13:10

Ticker Symbols

Name Symbol
Frankfurt OB3.F
London OPTI.L
More Shares
Investors who hold OPTIBIOTIX HLTH PLC LS-02 also have the following shares in their portfolio:
Türkiye Sise Ve Cam Fabrikalari A.S.
Türkiye Sise Ve Cam Fabrikalari A.S. Share
UNIVERSITY OF LIVERPOOL (THE) 3.375% BDS 26/05/55
UNIVERSITY OF LIVERPOOL (THE) 3.375% BDS 26/05/55 Bond